Tumor Cell Biology

Research output

Research output per year 2016 2018 2019 2020 2021 2022 2022

• 27 Article
• 9 Published meeting abstract
• 3 Doctoral Thesis (compilation)
• 1 Preprint (in preprint archive)

Research output per year

Research output per year

Search results

• 2022

  Breast cancer hypoxia in relation to prognosis and benefit from radiotherapy after breast-conserving surgery in a large, randomised trial with long-term follow-up

  Tutzauer, J., Sjöström, M., Holmberg, E., Karlsson, P., Killander, F., Leeb-Lundberg, L. M. F., Malmström, P., Niméus, E., Fernö, M. & Jögi, A., 2022, In: British Journal of Cancer. 126, 8, p. 1145-1156

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Hypoxia-Inducible Factor 1 100%
  • Segmental Mastectomy 90%
  • Hypoxia 62%
  • Radiotherapy 54%
  • Breast Neoplasms 50%

• How Reliable Are Gene Expression-Based and Immunohistochemical Biomarkers Assessed on a Core-Needle Biopsy? A Study of Paired Core-Needle Biopsies and Surgical Specimens in Early Breast Cancer

  Saghir, H., Veerla, S., Malmberg, M., Rydén, L., Ehinger, A., Saal, L. H., Vallon-Christersson, J., Borg, Å., Hegardt, C., Larsson, C., Haidar, A., Hedenfalk, I., Loman, N. & Kimbung, S., 2022 Aug 18, In: Cancers. 14, 16, p. 1-16 4000.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Large-Core Needle Biopsy 100%
  • Biomarkers 49%
  • Breast Neoplasms 48%
  • Gene Expression 45%
  • Progesterone Receptors 20%

• Induction of Breast Cancer Cell Apoptosis by TRAIL and Smac Mimetics: Involvement of RIP1 and cFLIP

  Holmgren, C., Sunström Thörnberg, E., Granqvist, V. & Larsson, C., 2022, In: Current Issues in Molecular Biology . 44, 10, p. 4803-4821 19 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • TNF-Related Apoptosis-Inducing Ligand 100%
  • Receptor-Interacting Protein Serine-Threonine Kinases 97%
  • CASP8 and FADD-Like Apoptosis Regulating Protein 54%
  • Caspase 8 53%
  • Breast Neoplasms 44%

• Mechanisms of TRAIL- and Smac mimetic-induced cell death and phenotypical changes in breast cancer

  Granqvist, V., 2022, Lund: Lund University, Faculty of Medicine. 102 p.

  Research output: Thesis › Doctoral Thesis (compilation)

  Open Access

  File
  91 Downloads (Pure)

• RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer

  Staaf, J., Häkkinen, J., Hegardt, C., Saal, L. H., Kimbung, S., Hedenfalk, I., Lien, T., Sørlie, T., Naume, B., Russnes, H., Marcone, R., Ayyanan, A., Brisken, C., Malterling, R. R., Asking, B., Olofsson, H., Lindman, H., Bendahl, P-O., Ehinger, A., Larsson, C., & 5 othersLoman, N., Rydén, L., Malmberg, M., Borg, Å. & Vallon-Christersson, J., 2022 Aug 16, In: npj Breast Cancer. 8, p. 1-17 94.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • RNA Sequence Analysis 100%
  • Breast Neoplasms 56%
  • Recurrence 51%
  • Biomarkers 29%
  • Drug Therapy 17%

• The combination of TRAIL and the Smac mimetic LCL-161 induces an irreversible phenotypic change of MCF-7 breast cancer cells

  Granqvist, V., Holmgren, C. & Larsson, C., 2022 Apr, In: Experimental and Molecular Pathology. 125, 104739.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • TNF-Related Apoptosis-Inducing Ligand 100%
  • Cell Death 74%
  • Breast Neoplasms 44%
  • Caspases 35%
  • Down-Regulation 32%

• UROSCAN and UROSCANSEQ: a large-scale multicenter effort towards translation of molecular bladder cancer subtypes into clinical practice–from biobank to RNA-sequencing in real time

  Liedberg, F., Abrahamsson, J., Bernardo, C., Bläckberg, M., Edsjö, A., Heidenblad, M., Larsson, C., Sjödahl, G. & Eriksson, P., 2022, (Accepted/In press) In: Scandinavian Journal of Urology.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • RNA Sequence Analysis 100%
  • Urinary Bladder Neoplasms 85%
  • Neoplasms 24%
  • Population 9%
  • RNA 8%
• 2021

  Combinatorial molecule screening identifies a novel diterpene and the BET inhibitor CPI-203 as differentiation inducers of primary acute myeloid leukemia cells

  Hultmark, S., Baudet, A., Schmiderer, L., Prabhala, P., Palma-Tortosa, S., Sandén, C., Fioretos, T., Sasidharan, R., Larsson, C., Lehmann, S., Juliusson, G., Ek, F. & Magnusson, M., 2021, In: Haematologica. 106, 10

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • cyclopropapyrroloindole 100%
  • Diterpenes 86%
  • Myeloid Cells 65%
  • Acute Myeloid Leukemia 61%
  • Protein Kinase C 36%

• Induction of interferon-β and interferon signaling by TRAIL and Smac mimetics via caspase-8 in breast cancer cells

  Granqvist, V., Holmgren, C. & Larsson, C., 2021, In: PLoS ONE. 16, 3 March, e0248175.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Caspase 8 100%
  • MCF-7 Cells 92%
  • Interferons 79%
  • Breast Neoplasms 55%
  • Phosphorylation 44%

• Predicting molecular phenotypes from histopathology images: A transcriptome-wide expression–morphology analysis in breast cancer

  Wang, Y., Kartasalo, K., Weitz, P., Acs, B., Valkonen, M., Larsson, C., Ruusuvuori, P., Hartman, J. & Rantalainen, M., 2021 Oct 1, In: Cancer Research. 81, 19, p. 5115-5126 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Transcriptome 100%
  • Breast Neoplasms 69%
  • Phenotype 65%
  • Messenger RNA 46%
  • Deep Learning 37%

• Preexisting Somatic Mutations of Estrogen Receptor Alpha (ESR1) in Early-Stage Primary Breast Cancer

  Dahlgren, M., George, A., Brueffer, C., Gladchuk, S., Chen, Y., Vallon-Christersson, J., Hegardt, C., Häkkinen, J., Ryden, L., Malmberg, M., Larsson, C., Gruvberger, S., Ehinger, A., Loman, N., Borg, Å. & Saal, L., 2021 Apr 22, In: JNCI Cancer Spectrum. 5, 2, pkab028.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Estrogen Receptor alpha 100%
  • Breast Neoplasms 55%
  • Mutation 48%
  • Fulvestrant 16%
  • Confidence Intervals 14%

• “Association of mammographic features with molecular breast tumor profiles”

  Sartor, H., Zackrisson, S., Hegardt, C. & Larsson, C., 2021, In: Cancer Treatment and Research Communications. 28, 100387.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Breast Neoplasms 100%
  • Neoplasms 50%
  • Genes 44%
  • Breast Density 42%
  • Breast 23%
• 2020

  Abstract CT074: Pre-existing ESR1 mutations in early-stage primary breast cancer predict failure of endocrine therapy and poor survival

  Dahlgren, M., George, A., Brueffer, C., Gladchuk, S., Chen, Y., Vallon-Christersson, J., Hegardt, C., Häkkinen, J., Ryden, L., Malmberg, M., Larsson, C., Gruvberger, S., Ehinger, A., Loman, N., Borg, Å. & Saal, L., 2020 Aug, In: Cancer research. Supplement. 80, 16

  Research output: Contribution to journal › Published meeting abstract

• Abstract P1-18-10: Preoperative treatment of HER2-positive breast cancer in South Sweden. A retrospective, comprehensive survey of neo-adjuvant treated HER2-positve breast cancer in the SCAN-B project 2010-2017

  Malmberg, M., Larsson, C., Vallon-Christersson, J., Ehinger, A., Hegardt, C., Killander, F., Ryden, L., Saal, L., Loman, N. & Borg, Å., 2020 Feb, In: Cancer research. Supplement. 80, Issue 4 Supplement, p. P1-18-10

  Research output: Contribution to journal › Published meeting abstract

• Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers

  Glodzik, D., Bosch, A., Hartman, J., Aine, M., Vallon-Christersson, J., Reuterswärd, C., Karlsson, A., Mitra, S., Niméus, E., Holm, K., Häkkinen, J., Hegardt, C., Saal, L. H., Larsson, C., Malmberg, M., Rydén, L., Ehinger, A., Loman, N., Kvist, A., Ehrencrona, H., & 3 othersNik-zainal, S., Borg, Å. & Staaf, J., 2020, In: Nature Communications. 11, 1, 3747.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • RNA Sequencing 100%
  • Adjuvant 74%
  • Triple Negative Breast Neoplasms 72%
  • breast 63%
  • cancer 56%

• Defining the mutational landscape of 3,217 primary breast cancer transcriptomes through large-scale RNA-seq within the Sweden Cancerome Analysis Network: Breast Project (SCAN-B; NCT03430492).

  Brueffer, C., Gladchuk, S., Winter, C., Vallon-christersson, J., Hegardt, C., Häkkinen, J., George, A. M., Chen, Y., Ehinger, A., Larsson, C., Loman, N., Malmberg, M., Rydén, L., Borg, Å. & Saal, L. H., 2020 May 20, In: Journal of Clinical Oncology. 38, 15_suppl, p. 518-518

  Research output: Contribution to journal › Published meeting abstract

• Inflammatory macrophage derived TNFα downregulates estrogen receptor α via FOXO3a inactivation in human breast cancer cells

  Gunnarsdóttir, F. B., Hagerling, C., Bergenfelz, C., Mehmeti, M., Källberg, E., Allaoui, R., Mohlin, S., Påhlman, S., Larsson, C., Jirström, K., Bexell, D. & Leandersson, K., 2020 May 1, In: Experimental Cell Research. 390, 1, 111932.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Estrogen Receptors 100%
  • Tumor Necrosis Factor-alpha 76%
  • Down-Regulation 74%
  • Macrophages 74%
  • Breast Neoplasms 68%

• Prognostic implications of the expression levels of different immunoglobulin heavy chain-encoding RNAs in early breast cancer

  Larsson, C., Ehinger, A., Winslow, S., Leandersson, K., Klintman, M., Dahl, L., Vallon-christersson, J., Häkkinen, J., Hegardt, C., Manjer, J., Saal, L., Rydén, L., Malmberg, M., Borg, Å. & Loman, N., 2020 Jul 6, In: npj Breast Cancer. 6, 1, 28.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Immunoglobulin Heavy Chains 100%
  • RNA 53%
  • Breast Neoplasms 49%
  • Messenger RNA 37%
  • Immunoglobulin Isotypes 12%

• The Mutational Landscape of the SCAN-B Real-World Primary Breast Cancer Transcriptome

  Brueffer, C., Gladchuk, S., Winter, C., Vallon-Christersson, J., Hegardt, C., Häkkinen, J., George, A., Chen, Y., Ehinger, A., Larsson, C., Loman, N., Malmberg, M., Ryden, L., Borg, Å. & Saal, L., 2020 Jan 31, bioRxiv.

  Research output: Working paper/Preprint › Preprint (in preprint archive)

• The mutational landscape of the SCAN‐B real‐world primary breast cancer transcriptome

  Brueffer, C., Gladchuk, S., Winter, C., Vallon-Christersson, J., Hegardt, C., Häkkinen, J., George, A., Chen, Y., Ehinger, A., Larsson, C., Loman, N., Malmberg, M., Ryden, L., Borg, Å. & Saal, L., 2020 Sep 14, In: EMBO Molecular Medicine. 12, 10, e12118.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Transcriptome 100%
  • Breast Neoplasms 69%
  • Mutation 45%
  • Datasets 21%
  • Biomarkers 17%

• Whole-genome sequencing of triple negative breast cancers in a standard population-based clinical setting

  Staaf, J., Glodzik, D., Bosch Campos, A., Vallon-Christersson, J., Reuterswärd, C., Häkkinen, J., Degasperi, A., Amarante, T. D., Saal, L., Hegardt, C., Stobart, H., Ehinger, A., Larsson, C., Ryden, L., Loman, N., Malmberg, M., Kvist, A., Ehrencrona, H., Davies, H. R., Borg, Å., & 1 othersNik-Zainal, S., 2020 Feb 6, In: Breast Cancer Research and Treatment. 180, p. 531-532

  Research output: Contribution to journal › Published meeting abstract
• 2019

  Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer

  Lundgren, C., Bendahl, P-O., Ehinger, A., Hegardt, C., Larsson, C., Loman, N., Malmberg, M., Olofsson, H., Saal, L., Sjoblom, T., Lindman, H., Klintman, M., Häkkinen, J., Vallon-Christersson, J., Fernö, M., Rydén, L. & Ekholm, M., 2019 Aug 20, In: Breast Cancer Research and Treatment. p. 1-9 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Beta-sheet-specific interactions with heat shock proteins define a mechanism of delayed tumor cell death in response to HAMLET

  Nadeem, A., Ho, J. C. S., Tran, T. H., Paul, S., Granqvist, V., Despretz, N. & Svanborg, C., 2019, In: Journal of Molecular Biology. 431, 14, p. 2612-2627

  Research output: Contribution to journal › Article › peer-review

  • beta-Strand Protein Conformation 100%
  • Heat-Shock Proteins 87%
  • Cell Death 63%
  • Lactalbumin 33%
  • Neoplasms 27%

• Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series

  Vallon-Christersson, J., Häkkinen, J., Hegardt, C., Saal, L., Larsson, C., Ehinger, A., Lindman, H., Olofsson, H., Sjoblom, T., Wärnberg, F., Rydén, L., Loman, N., Malmberg, M., Borg, Å. & Staaf, J., 2019 Aug 21, In: Scientific Reports. 9, 12184.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Breast Neoplasms 100%
  • Population 61%
  • Genes 25%
  • Therapeutics 23%
  • erbB-2 Genes 21%

• Prediction of lymph node metastasis in breast cancer by gene expression and clinicopathological models: Development and validation within a population based cohort.

  Dihge, L., Vallon-Christersson, J., Hegardt, C., Saal, L., Häkkinen, J., Larsson, C., Ehinger, A., Loman, N., Malmberg, M., Bendahl, P-O., Borg, Å., Staaf, J. & Rydén, L., 2019 Jul 24, In: Clinical Cancer Research. 25, 21, p. 6368-6381

  Research output: Contribution to journal › Article › peer-review

  • Neoplasm Genes 100%
  • Sentinel Lymph Node Biopsy 92%
  • Lymph Nodes 65%
  • Breast Neoplasms 58%
  • Neoplasm Metastasis 57%

• Refinement of breast cancer molecular classification by miRNA expression profiles

  Søkilde, R., Persson, H., Ehinger, A., Pirona, A. C., Fernö, M., Hegardt, C., Larsson, C., Loman, N., Malmberg, M., Rydén, L., Saal, L., Borg, Å., Vallon-Christerson, J. & Rovira, C., 2019 Jun 17, In: BMC Genomics. 20, 1, 12 p., 503.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • MicroRNAs 100%
  • Breast Neoplasms 75%
  • Neoplasm Genes 18%
  • Neoplasms 16%
  • Transcriptome 15%

• Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study

  Staaf, J., Glodzik, D., Bosch, A., Vallon-Christersson, J., Reuterswärd, C., Häkkinen, J., Degasperi, A., Amarante, T. D., Saal, L. H., Hegardt, C., Stobart, H., Ehinger, A., Larsson, C., Rydén, L., Loman, N., Malmberg, M., Kvist, A., Ehrencrona, H., Davies, H. R., Borg, Å., & 1 othersNik-Zainal, S., 2019, In: Nature Medicine. 25, p. 1526–1533

  Research output: Contribution to journal › Article › peer-review

  • Adjuvant 100%
  • Triple Negative Breast Neoplasms 97%
  • Whole Genome Sequencing 94%
  • Mutation 68%
  • Clinical Studies 56%
• 2018

  Abstract P1-06-01: Putting multigene signatures to the test: Prognostic assessment in population-based contemporary clinical breast cancer

  Staaf, J., Vallon-Christersson, J., Häkkinen, J., Saal, L., Hegardt, C., Larsson, C., Ehinger, A., Rydén, L., Loman, N., Malmberg, M. & Borg, Å., 2018 Feb, In: Cancer research. Supplement. 78, 4

  Research output: Contribution to journal › Published meeting abstract › peer-review

  Open Access

  • Breast Neoplasms 100%
  • Population 61%
  • Trastuzumab 26%
  • Therapeutics 25%
  • Survival 18%

• Abstract P2-02-09: Breast cancer subtype distribution and circulating tumor DNA in response to neoadjuvant chemotherapy: Experiences from a preoperative cohort within SCAN-B

  Loman, N., Chen, Y., Aaltonen, K., Brueffer, C., George, A., Zander, L., Vallon-Christersson, J., Häkkinen, J., Förnvik, D., Rigo, R., Ehinger, A., Malmberg, M., Larsson, C., Hegardt, C., Borg, Å., Rydén, L. & Saal, L., 2018 Feb, In: Cancer research. Supplement. 78, 4

  Research output: Contribution to journal › Published meeting abstract › peer-review

  Open Access

  • Circulating Tumor DNA 100%
  • Breast Neoplasms 44%
  • Drug Therapy 40%
  • RNA Sequence Analysis 19%
  • Biopsy 15%

• Abstract P3-02-02: Concordance between immunohistochemical and gene-expression based subtyping of early breast cancer using core needle biopsies and surgical specimens - experices from SCAN-B

  Morgan, G., Larsson, C., Tahin, B., Vallon-Christersson, J., Häkkinen, J., Ehinger, A., Malmberg, M., Hegardt, C., Borg, Å., Rydén, L., Saal, L., Hedenfalk, I. & Loman, N., 2018 Feb, In: Cancer research. Supplement. 78, 4

  Research output: Contribution to journal › Published meeting abstract › peer-review

  Open Access

  • Large-Core Needle Biopsy 100%
  • Biomarkers 49%
  • Breast Neoplasms 48%
  • Gene Expression 45%
  • Carcinoma, Intraductal, Noninfiltrating 45%

• Abstract P4-09-03: On the development and clinical value of RNA-sequencing-based classifiers for prediction of the five conventional breast cancer biomarkers: A report from the population-based multicenter SCAN-B study

  Brueffer, C., Vallon-Christersson, J., Grabau, D., Ehinger, A., Häkkinen, J., Hegardt, C., Malina, J., Chen, Y., Bendahl, P-O., Manjer, J., Malmberg, M., Larsson, C., Loman, N., Rydén, L., Borg, Å. & Saal, L., 2018 Feb, In: Cancer research. Supplement. 78, 4

  Research output: Contribution to journal › Published meeting abstract › peer-review

  Open Access

  • RNA-Seq 100%
  • RNA Sequence Analysis 96%
  • Tumor Biomarkers 83%
  • Breast Neoplasms 54%
  • Biomarkers 47%

• Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative

  Brueffer, C., Vallon-Christersson, J., Grabau, D., Ehinger, A., Häkkinen, J., Hegardt, C., Malina, J., Chen, Y., Bendahl, P-O., Manjer, J., Malmberg, M., Larsson, C., Loman, N., Rydén, L., Borg, Å. & Saal, L. H., 2018 Mar 9, In: JCO Precision Oncology. 2, p. 1-18

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • RNA-Seq 100%
  • Sweden 83%
  • Tumor Biomarkers 83%
  • Hormones 60%
  • RNA 59%

• Gene expression of the two developmentally regulated dermatan sulfate epimerases in the Xenopus embryo

  Gouignard, N., Schön, T., Holmgren, C., Strate, I., Taşöz, E., Wetzel, F., Maccarana, M. & Pera, E. M., 2018 Jan 1, In: PLoS ONE. 13, 1, e0191751.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Racemases and Epimerases 100%
  • Dermatan Sulfate 92%
  • Chondroitin Sulfates 80%
  • Xenopus 69%
  • dermatan sulfate proteoglycan 54%

• Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling

  Roswall, P., Bocci, M., Bartoschek, M., Li, H., Kristiansen, G., Jansson, S., Lehn, S., Sjölund, J., Reid, S., Larsson, C., Eriksson, P., Anderberg, C., Cortez, E., Saal, L. H., Orsmark-Pietras, C., Cordero, E., Haller, B. K., Häkkinen, J., Burvenich, I. J. G., Lim, E., & 7 othersOrimo, A., Höglund, M., Rydén, L., Moch, H., Scott, A. M., Eriksson, U. & Pietras, K., 2018 Mar 12, In: Nature Medicine. 24, p. 463–473

  Research output: Contribution to journal › Article › peer-review

  • Platelet-Derived Growth Factor 100%
  • Hormone 86%
  • Cancer-Associated Fibroblasts 72%
  • Breast Neoplasms 55%
  • Hormones 24%

• Minimizing inequality in access to precision medicine in breast cancer by real-time population-based molecular analysis in the SCAN-B initiative

  Rydén, L., Loman, N., Larsson, C., Hegardt, C., Vallon-Christersson, J., Malmberg, M., Lindman, H., Ehinger, A., Saal, L. H. & Borg, Å., 2018 Jan 17, In: British Journal of Surgery. 105, 2, p. e158–e168

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Precision Medicine 100%
  • Sweden 90%
  • Breast 70%
  • Breast Neoplasms 59%
  • Population 36%

• Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing

  Bartoschek, M., Oskolkov, N., Bocci, M., Lövrot, J., Larsson, C., Sommarin, M., Madsen, C., Lindgren, D., Pekar, G., Karlsson, G., Ringnér, M., Bergh, J., Björklund, Å. K. & Pietras, K., 2018 Dec 4, In: Nature Communications. 9, 1, 5150.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • RNA Sequencing 100%
  • Cancer-Associated Fibroblasts 84%
  • sequencing 81%
  • fibroblasts 75%
  • RNA Sequence Analysis 67%
• 2017

  Abstract P1-07-17: The SCAN-B study: 5-year summary of a large-scale population-based prospective breast cancer translational genomics platform covering a wide geography of Sweden (NCT02306096)

  Saal, L., Hegardt, C., Vallon-Christersson, J., Häkkinen, J., Ehinger, A., Manjer, J., Larsson, C., Loman, N., Rydén, L., Malmberg, M. & Borg, Å., 2017 Feb, In: Cancer Research. 77, 4 Suppl

  Research output: Contribution to journal › Published meeting abstract › peer-review

• Inflammatory Cells and Mediators in the Tumor Microenvironment of Breast Cancer

  Allaoui, R., 2017, Lund: Lund University: Faculty of Medicine. 74 p.

  Research output: Thesis › Doctoral Thesis (compilation)

  Open Access

  File
  1071 Downloads (Pure)

• Smac and Smac mimetics in breast cancer cell death

  Holmgren, C., 2017, Lund: Lund University: Faculty of Medicine. 78 p.

  Research output: Thesis › Doctoral Thesis (compilation)
• 2016

  PKC activation sensitizes basal-like breast cancer cell lines to Smac mimetics

  Cornmark, L., Holmgren, C., Masoumi, K. & Larsson, C., 2016, In: Cell death discovery. 2, p. 16002

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • LBW242 100%
  • Protein Kinase C 50%
  • Cell Death 40%
  • Breast Neoplasms 34%
  • Cell Line 31%